Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 50925-79-6
Drug Levels and Effects
Summary of Use during Lactation
Colestipol is a nonabsorbable resin. Because it does not enter the mother's bloodstream, it will not reach the infant via breastmilk. It is acceptable for use during lactation.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
(Hypercholesterolemia) Cholestyramine, Colesevelam; (Type 2 Diabetes) Acarbose, Glipizide, Glyburide, Insulin, Metformin, Miglitol
Substance Identification
Substance Name
Colestipol
CAS Registry Number
50925-79-6
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Cholestyramine.[Drugs and Lactation Database (...]Review Cholestyramine.. Drugs and Lactation Database (LactMed®). 2006
- Review Colesevelam.[Drugs and Lactation Database (...]Review Colesevelam.. Drugs and Lactation Database (LactMed®). 2006
- Primary hypercholesterolemia: effect of treatment on serum lipids, lipoprotein fractions, cholesterol absorption, sterol balance, and platelet aggregation.[Mayo Clin Proc. 1984]Primary hypercholesterolemia: effect of treatment on serum lipids, lipoprotein fractions, cholesterol absorption, sterol balance, and platelet aggregation.Briones ER, Steiger D, Palumbo PJ, Kottke BA. Mayo Clin Proc. 1984 Apr; 59(4):251-7.
- The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.[J Clin Invest. 1973]The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.Goodman DS, Noble RP, Dell RB. J Clin Invest. 1973 Oct; 52(10):2646-55.
- Controlled studies of the efficacy and safety of combined probucol-colestipol therapy.[Am J Cardiol. 1986]Controlled studies of the efficacy and safety of combined probucol-colestipol therapy.Dujovne CA, Krehbiel P, Chernoff SB. Am J Cardiol. 1986 Jun 27; 57(16):36H-42H.
- Colestipol - Drugs and Lactation Database (LactMed®)Colestipol - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...